Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-03-19

FDA Approved: DANAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for danazol from Teva Pharmaceuticals USA, Inc. The approval updates the drug's labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danazol (danazol)

Snippet

SUPPL AP for DANAZOL (DANAZOL)